NCT01517035View on ClinicalTrials.gov

Improving Blood Stem Cell Collection and Transplant Procedures

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

43

Participants

Timeline

Start Date

January 13, 2012

Primary Completion Date

March 29, 2017

Study Completion Date

March 29, 2017

Conditions
Myelodysplastic Syndrome (MDS)Chronic Myelogenous LeukemiaAcute Lymphoblastic LeukemiaCML (Chronic Myelogenous LeukemiaCLL (Chronic Lymphocytic Leukemia)
Interventions
PROCEDURE

Stem Cell Transplantation

Myeloablative conditioning (Flu/Cy/TBI) followed by CD3/19/34 selected stem cell graft.

Trial Locations (1)

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

All Listed Sponsors
lead

National Heart, Lung, and Blood Institute (NHLBI)

NIH

NCT01517035 - Improving Blood Stem Cell Collection and Transplant Procedures | Biotech Hunter | Biotech Hunter